CymaBay (NASDAQ: CBAY) Stock Soars as Gilead Sciences Unveils $4.3 Billion Takeover Bid
CymaBay Therapeutics (NASDAQ: CBAY) stock skyrocketed after Gilead Sciences (GILD) announced to acquire the liver disease drugmaker for $4.3 billion […]
CymaBay (NASDAQ: CBAY) Stock Soars as Gilead Sciences Unveils $4.3 Billion Takeover Bid Read More »